-
Verucerfont (GSK-561,679) is a drug
developed by
GlaxoSmithKline which acts as a CRF-1 antagonist.
Corticotropin releasing factor (CRF), also
known as...
-
versetamide (INN)
Versiclear Vertavis verteporfin verubulin (USAN, INN)
verucerfont (USAN, INN)
Verzenio Verzenios Vesanoid vesen****ab (INN)
Vesicare Vesicare...
-
Corticotropin releasing hormone antagonists Antalarmin CP-154,526
Emicerfont Verucerfont "International
Nonproprietary Names for
Pharmaceutical Substances (INN)...
-
Tradipitant (LY-686017; VLY-686) –
neurokinin NK1
receptor antagonist Verucerfont (GSK-561679; NBI-77860) – corticotropin-releasing
hormone receptor 1...
-
receptor Corticotropin-releasing
hormone antagonist Antalarmin Pexacerfont Verucerfont GRCm38:
Ensembl release 89: ENSMUSG00000018634 – Ensembl, May 2017 "Human...
-
Corticotropin releasing hormone antagonists Antalarmin Pexacerfont Verucerfont Hubbard CS,
Labus JS,
Bueller J,
Stains J,
Suyenobu B,
Dukes GE, et al...
-
Emicerfont Hypericin LWH-234 NBI-27914 NBI-74788
Pexacerfont R-121919 TS-041
Verucerfont Agonists Corticorelin Corticotropin-releasing
hormone Sauvagine Urocortin...
-
Vanoxerine (boxeprazine; GBR-12909) –
atypical dopamine reuptake inhibitor Verucerfont (GSK-561679; NBI-77860) –
corticotropin releasing factor receptor 1 (CRF1)...
-
Emicerfont Hypericin LWH-234 NBI-27914 NBI-74788
Pexacerfont R-121919 TS-041
Verucerfont Agonists:
Corticorelin Corticotropin-releasing
hormone Sauvagine Urocortin...
